"Patients in Katy, Memorial, Spring Branch and the surrounding Energy Corridor have convenient access to top-ranked, comprehensive cancer care at MD Anderson West Houston. Here, patients will find convenient and comprehensive multidisciplinary care, from screenings to survivorship and everything in between. While we treat all types of cancers in West Houston, the faculty here has particular expertise in the diagnosis, treatment and management of the following cancers: Breast Colorectal Dermatology and skin Endocrine Genitourinary Gynecologic Head and neck Neurologic Thoracic Urology"

During the past decade, MD Anderson West Houston conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 8 clinical trials were completed, i.e. on average, 16.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MD Anderson West Houston" #1 sponsor was "M.D. Anderson Cancer Center" with 24 trials, followed by "National Cancer Institute (NCI)" with 14 trials sponsored, "NRG Oncology" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MD Anderson West Houston" #1 collaborator was "National Cancer Institute (NCI)" with 42 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "MD Anderson West Houston" are "Invasive Breast Carcinoma" (7 trials), "Triple-Negative Breast Carcinoma" (6 trials), "Stage II Breast Cancer AJCC v6 and v7" (5 trials), "Stage I Breast Cancer AJCC v7" (4 trials) and "Stage IA Breast Cancer AJCC v7" (4 trials). Many other conditions were trialed in "MD Anderson West Houston" in a lesser frequency.

Most popular intervention types in "MD Anderson West Houston" are "Other" (46 trials), "Drug" (41 trials), "Radiation" (26 trials), "Procedure" (24 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (24 trials), "Quality-of-Life Assessment" (20 trials), "Questionnaire Administration" (14 trials), "Carboplatin" (11 trials) and "Paclitaxel" (11 trials). Other intervention names were less common.

The vast majority of trials in "MD Anderson West Houston" are 38 trials for "All" genders, 19 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "MD Anderson West Houston". undefined are not yet recruiting, 26 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in MD Anderson West Houston, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MD Anderson West Houston, 5 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".